Hypothesis

Restoring circadian amplitude through timed NAD+ supplementation reopens BMAL1:CLOCK binding sites at specific enhancer clusters, thereby rescuing chromatin accessibility and reversing epigenetic drift in aged tissues.

Mechanistic Basis

The circadian clock drives rhythmic transcription of clock‑controlled genes (CCGs) that govern DNA repair, autophagy, mitochondrial redox balance and proteostasis [1]. Age‑associated loss of chromatin accessibility reduces BMAL1:CLOCK peaks from >8,000 in young muscle to <200 in old muscle, a >95% decline that directly compromises multiple repair pathways [2]. NAD+ levels fall with age, diminishing SIRT1 activity, which normally deacetylates BMAL1 and PER2 to couple metabolic state to clock function [5]. SIRT1 also deacetylates histones at clock‑controlled enhancers, promoting a permissive chromatin state. We propose that bolus NAD+ elevation, delivered at the circadian trough of NAD+ biosynthesis (subjective night), transiently activates SIRT1, leading to histone deacetylation and increased BMAL1:CLOCK occupancy at a subset of enhancers that regulate CCGs for DNA damage response (e.g., XPA) and autophagy (e.g., LC3B). Restored enhancer accessibility re‑establishes rhythmic CCG expression, thereby re‑engaging the circadian firewall.

Predictions & Experimental Design

1. Chromatin Accessibility Rescue – Aged mice (24 mo) receiving timed nicotinamide riboside (NR) injections at ZT14 (subjective night) for 4 weeks will show a ≥2‑fold increase in ATAC‑seq peaks at BMAL1:CLOCK binding sites compared with vehicle‑treated controls, peaking at ZT2‑ZT6.
2. CCG Rhythmicity – RNA‑seq from harvested muscle will reveal restored amplitude (≥30% increase) of CCGs such as XPA, LC3B, and SOD2, with phase aligned to the light‑dark cycle.
3. Functional Outcomes – Treated animals will exhibit reduced γH2AX foci (DNA damage), increased autophagic flux (LC3‑II/I ratio), and improved mitochondrial membrane potential (JC‑1 assay) relative to controls.
4. Falsifiability – If timed NR fails to increase ATAC‑seq peaks or CCG rhythmicity, or if SIRT1 inhibition (using EX527) abolishes the effect, the hypothesis is refuted.

Potential Implications

This work links NAD+ metabolism, sirtuin activity, and chromatin dynamics to the circadian firewall concept, offering a testable, mechanism‑based geroprotective strategy. Successful validation would justify circadian‑timed NAD+ boosting as a non‑invasive intervention to restore temporal coherence and delay multimorbidity in aging populations.

[1] [2] [5]